NCT04504942 2026-01-23Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid TumorsCytoDyn, Inc.Phase 2 Completed16 enrolled 16 charts
NCT03838367 2025-09-09Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBCCytoDyn, Inc.Phase 1/2 Terminated10 enrolled 15 charts